SUZHOU HIGHFINE BIOTECH CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 45.32 CNY | -0.29% |
|
-6.23% | -24.48% |
| Sales 2024 * | 672M 92.71M | Sales 2025 * | 888M 123M | Capitalization | 4.89B 674M |
|---|---|---|---|---|---|
| Net income 2024 * | 194M 26.78M | Net income 2025 * | 257M 35.48M | EV / Sales 2024 * | 7.27 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 5.5 x |
| P/E ratio 2024 * |
25.2
x | P/E ratio 2025 * |
19
x | Employees | - |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 26.27% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.29% | ||
| 1 week | -6.23% | ||
| Current month | +3.68% | ||
| 1 month | +9.50% | ||
| 3 months | -10.31% | ||
| 6 months | -38.07% | ||
| Current year | -24.48% |
1 week
44.09
49.38
1 month
41.2558.22
Current year
36.5160.88
1 year
36.51118.88
3 years
36.51118.88
5 years
36.51118.88
10 years
36.51118.88
| Managers | Title | Age | Since |
|---|---|---|---|
Yong Zhu
CEO | Chief Executive Officer | 53 | 03-12-01 |
Xiao Yan Wang
DFI | Director of Finance/CFO | 44 | 04-01-31 |
Hao Yi Sun
CHM | Chairman | 46 | 11-06-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Qing Wang
BRD | Director/Board Member | 58 | 21-05-31 |
Yong Zhu
CEO | Chief Executive Officer | 53 | 03-12-01 |
Jie Xu
BRD | Director/Board Member | 45 | 04-10-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-27 | 45.32 | -0.29% | 1,314,912 |
| 24-05-24 | 45.45 | -1.20% | 1,523,848 |
| 24-05-23 | 46 | -4.07% | 1,975,977 |
| 24-05-22 | 47.95 | +0.40% | 1,558,920 |
| 24-05-21 | 47.76 | -2.71% | 2,183,554 |
End-of-day quote Shenzhen S.E., May 26, 2024
More quotes
Suzhou Highfine Biotech Co Ltd is a China-based company mainly engaged in the research and development (R&D), production and sales of Peptide synthesis reagents. The Company's main products include Peptide synthesis reagents such as condensation reagents, protection reagents and chiral racemic inhibition reagents, general-purpose molecular blocks and protein reagents.
Sector
Commodity Chemicals
Calendar
2024-08-15
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
45.32
Average target price
-
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -24.48% | 677M | |
| +4.29% | 103B | |
| -8.62% | 60.95B | |
| +68.57% | 49.09B | |
| +17.86% | 38.46B | |
| +3.64% | 32.09B | |
| +13.29% | 20.39B | |
| +13.00% | 16.78B | |
| +11.62% | 14.76B | |
| +1.45% | 13.73B |
- Stock Market
- Equities
- 301393 Stock
